Cardiac gene therapy stands at the forefront of revolutionary advancements in cardiovascular medicine, presenting a transformative approach to address a spectrum of heart-related challenges. This cutting-edge therapeutic method involves the precise introduction of specific genes into the cardiac system, aiming to rectify genetic anomalies, optimize myocardial performance, and impede the progression of various cardiac conditions. Through innovative gene delivery systems, researchers are delving into the possibilities of targeting conditions like arrhythmias and ischemic heart disease, paving the way for tailored interventions that go beyond traditional treatments. The dynamic landscape of cardiac gene therapy underscores a new era in cardiac care, offering a glimpse into the potential for highly individualized and impactful interventions that could redefine the future of cardiovascular health. As the field continues to evolve, the prospect of reshaping the landscape of cardiac medicine through gene-based therapies emerges as an exciting avenue of exploration and progress.
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Young hearts at risk: Hidden cardiovascular damage and the role of social determinants of health among youth with type 1 diabetes in Kenya
Phoebe Wamalwa, Ministry of Health, Kenya